Literature DB >> 35124780

Prenatal Androgen Exposure and Traits of Autism Spectrum Disorder in the Offspring: Odense Child Cohort.

Camilla V B Palm1,2, Dorte Glintborg3,4, Laura G Find1,2,5, Pia V Larsen6, Cilia M Dalgaard1,2,5, Henriette Boye7,8, Tina K Jensen7,8,9, Anja F Dreyer1,2, Marianne S Andersen1,2, Niels Bilenberg2,5.   

Abstract

Fetal androgen exposure may be associated with autism spectrum disorder (ASD). We studied 1777 mother-child pairs in the prospective Odense Child Cohort. Prenatal androgen exposure was assessed by maternal 3rd trimester testosterone concentrations, maternal polycystic ovary syndrome (PCOS), and 3 months offspring anogenital distance. ASD traits were assessed at age 3 years with the ASD-symptom scale of the Child Behavior Checklist for ages 1½-5 years. Maternal testosterone was positively associated with traits of ASD in boys (p < 0.05). Maternal PCOS was associated with increased offspring ASD traits (p = 0.046), but became non-significant after excluding parental psychiatric diagnosis. Offspring anogenital distance was not linked to ASD traits. Higher prevalence of ASD in boys could be linked to higher susceptibility to fetal androgen exposure.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Autism spectrum; Birth cohort; Prenatal; Testosterone

Year:  2022        PMID: 35124780     DOI: 10.1007/s10803-022-05446-w

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  57 in total

1.  The extreme male brain theory of autism.

Authors:  Simon Baron-Cohen
Journal:  Trends Cogn Sci       Date:  2002-06-01       Impact factor: 20.229

Review 2.  Sex differences in the brain: implications for explaining autism.

Authors:  Simon Baron-Cohen; Rebecca C Knickmeyer; Matthew K Belmonte
Journal:  Science       Date:  2005-11-04       Impact factor: 47.728

3.  Variation by diagnostic subtype in risk for autism spectrum disorders associated with maternal parity among Finnish births.

Authors:  Keely Cheslack-Postava; Elina Jokiranta; Auli Suominen; Venla Lehti; Andre Sourander; Alan S Brown
Journal:  Paediatr Perinat Epidemiol       Date:  2013-11-08       Impact factor: 3.980

4.  Steroids in human intrauterine fluids of early pregnancy.

Authors:  G Atkinson; D J Campbell; M L Cawood; R E Oakey
Journal:  Clin Endocrinol (Oxf)       Date:  1996-04       Impact factor: 3.478

5.  Fetal testosterone and autistic traits.

Authors:  Bonnie Auyeung; Simon Baron-Cohen; Emma Ashwin; Rebecca Knickmeyer; Kevin Taylor; Gerald Hackett
Journal:  Br J Psychol       Date:  2008-06-10

6.  Foetal testosterone and autistic traits in 18 to 24-month-old children.

Authors:  Bonnie Auyeung; Kevin Taylor; Gerald Hackett; Simon Baron-Cohen
Journal:  Mol Autism       Date:  2010-07-12       Impact factor: 7.509

Review 7.  Why are autism spectrum conditions more prevalent in males?

Authors:  Simon Baron-Cohen; Michael V Lombardo; Bonnie Auyeung; Emma Ashwin; Bhismadev Chakrabarti; Rebecca Knickmeyer
Journal:  PLoS Biol       Date:  2011-06-14       Impact factor: 8.029

8.  Polycystic ovary syndrome and autism: A test of the prenatal sex steroid theory.

Authors:  Adriana Cherskov; Alexa Pohl; Carrie Allison; Heping Zhang; Rupert A Payne; Simon Baron-Cohen
Journal:  Transl Psychiatry       Date:  2018-08-01       Impact factor: 6.222

9.  Maternal polycystic ovary syndrome and risk of neuropsychiatric disorders in offspring: prenatal androgen exposure or genetic confounding?

Authors:  Carolyn E Cesta; Anna S Öberg; Abraham Ibrahimson; Ikram Yusuf; Henrik Larsson; Catarina Almqvist; Brian M D'Onofrio; Cynthia M Bulik; Lorena Fernández de la Cruz; David Mataix-Cols; Mikael Landén; Mina A Rosenqvist
Journal:  Psychol Med       Date:  2019-03-12       Impact factor: 7.723

10.  Elevated fetal steroidogenic activity in autism.

Authors:  S Baron-Cohen; B Auyeung; B Nørgaard-Pedersen; D M Hougaard; M W Abdallah; L Melgaard; A S Cohen; B Chakrabarti; L Ruta; M V Lombardo
Journal:  Mol Psychiatry       Date:  2014-06-03       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.